lunes, 30 de julio de 2018

New FREE Continuing Education from MMWR and Medscape Containing Unusual Antibiotic Resistance

MMWR Logo

New FREE Continuing Education from MMWR and Medscape
Containing Unusual Antibiotic Resistance

CDC’s MMWR and Medscape are proud to introduce a new FREE continuing education (CE) activity that describes changes in the proportion of unusual antibiotic resistance among selected pathogens, based on a CDC study. 

The figure above is an official graphic of a young girl receiving a tetanus vaccine with the CDC and MMWR logos and text that reads: New Free Continuing Education from MMWR and Medscape.


This activity is intended for infectious disease practitioners, critical care practitioners, hematologists/oncologists, internists, laboratory practitioners, pathologists, public health officials, urologists, nurses, pharmacists, and other clinicians who treat and manage patients with multidrug-resistant organism infection.
Upon completion of this activity, participants will be able to
  1. Describe changes from 2006 to 2015 in the annual proportion of selected pathogens that were nonsusceptible to extended-spectrum cephalosporins (ESBL phenotype) or resistant to carbapenems (carbapenem-resistant Enterobacteriaceae [CRE]), based on infection data from the National Healthcare Safety Network
  2. Describe findings from January to September 2017 of carbapenemase testing and screening tests, based on a Centers for Disease Control and Prevention (CDC) study
  3. Describe clinical implications of changes in spread of two multidrug-resistant (MDR) pathogens over time, based on a CDC study
To access this FREE MMWR / Medscape CE activity visit https://www.cdc.gov/mmwr/cme/medscape_cme.html. If you are not a registered user on Medscape, you may register for free or login without a password and get unlimited access to all continuing education activities and other Medscape features.



Follow CDC on FacebookFollow CDC on Twitter
@CDCMMWR & @Medscape introduce new FREE continuing education on approaches to controlling emerging antibiotic resistance in health care settings: https://go.usa.gov/xUm3E

No hay comentarios:

Publicar un comentario